Shearman, Paul Hastings lead on Jinxin Fertility’s $390 mln Hong Kong IPO(双语)
BY Ines Yang |
Shearman & Sterling and Fangda Partners have represented Chinese assisted reproductive services (ARS) provider Jinxin Fertility Group on its $390 million Hong Kong IPO, with Paul Hastings and Commerce & Finance Law Offices advising the joint sponsors and underwriters.